OPRX
Optimizerx·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 6
Bearish signal 0
Consensus Rating "Buy"
Ample Liquidity
High Gross Profit Margin
High Cash/net Profit Ratio
Revenue Beats Expectation
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About OPRX
Optimizerx Corp.
A developer of novel, orally administered therapies for the treatment of chronic diseases, with a focus on gastrointestinal and metabolic disorders
260 Charles Street Suite 302, Waltham, MA 02453
--
Optimizerx Corp. was founded in Nevada. Optimizerx is a digital health technology company that enables life science organizations, healthcare providers and patients to interact care-centered at critical moments throughout the patient care process. Optimizerx connects more than 60 percent of U.S. healthcare providers and millions of patients with an intelligent technology platform embedded in a proprietary point-of-care network, helping patients start and continue using their medicines.
Earnings Call
Company Financials
EPS
OPRX has released its 2025 Q3 earnings. EPS was reported at 0.2, versus the expected 0.05, beating expectations. The chart below visualizes how OPRX has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
OPRX has released its 2025 Q3 earnings report, with revenue of 26.07M, reflecting a YoY change of 22.33%, and net profit of 779.00K, showing a YoY change of 108.54%. The Sankey diagram below clearly presents OPRX's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available



